Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
21.1M
-
Shares change
-
+19.7M
-
Total reported value, excl. options
-
$200M
-
Value change
-
+$186M
-
Number of buys
-
18
-
Number of sells
-
-1
-
Price
-
$9.75
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2021
22 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.1M shares
of 87.4M outstanding shares and own 24.15% of the company stock.
Largest 10 shareholders include FMR LLC (12M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.3M shares), Redmile Group, LLC (2.5M shares), Velan Capital Investment Management LP (600K shares), Parian Global Management LP (467K shares), VANGUARD GROUP INC (442K shares), Hongkou Capital LP (400K shares), Saba Capital Management, L.P. (400K shares), Alpine Global Management, LLC (385K shares), and CVI Holdings, LLC (200K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.